These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17243283)

  • 1. Some cold medicines move behind counter.
    Bren L
    FDA Consum; 2006; 40(4):18-9. PubMed ID: 17243283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Don't let decongestants squeeze your heart. As many over-the-counter decongestants get a new ingredient, you might want to look for alternatives.
    Harv Heart Lett; 2005 Nov; 16(3):3. PubMed ID: 16363037
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacists on the front lines in the fight against meth. A 50-state comparison of the laws regulating the retail sale of pseudoephedrine.
    Rigdon BA
    J Leg Med; 2012 Apr; 33(2):253-83. PubMed ID: 22694096
    [No Abstract]   [Full Text] [Related]  

  • 4. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for over-the-counter nasal decongestant drug products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Oct; 70(195):58974-7. PubMed ID: 16217879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schedules of controlled substances; table of excluded nonnarcotic products: nasal decongestant inhalers manufactured by Classic Pharmaceuticals, LLC. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2010 Mar; 75(55):13678-9. PubMed ID: 20383920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the 20% D-methamphetamine requirement for determining illicit use of methamphetamine in urine.
    Esposito FM; Crumpton S; Mitchell J; Flegel RR
    J Anal Toxicol; 2012 Jul; 36(6):399-404. PubMed ID: 22586207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of monograph for OTC nasal decongestant drug products. Final rule.
    Fed Regist; 2006 Aug; 71(147):83358[sic., should be 43358]-63. PubMed ID: 16892519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cold Turkey.
    Coombes R
    BMJ; 2007 Jun; 334(7605):1190-2. PubMed ID: 17556470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OTC, DTC, a stuffy nose, cocaine, and methamphetamine.
    Flaskerud JH; Strehlow AJ
    Issues Ment Health Nurs; 2008 Sep; 29(9):1041-4. PubMed ID: 18770107
    [No Abstract]   [Full Text] [Related]  

  • 10. Are methamphetamine precursor control laws effective tools to fight the methamphetamine epidemic?
    Nonnemaker J; Engelen M; Shive D
    Health Econ; 2011 May; 20(5):519-31. PubMed ID: 21433216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, abuse, and toxicity of over-the-counter cough and cold medicines in the pediatric population.
    Carr BC
    Curr Opin Pediatr; 2006 Apr; 18(2):184-8. PubMed ID: 16601501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconsidering the safety of over-the-counter decongestants.
    Caravati EM
    Ann Emerg Med; 2005 Feb; 45(2):217-8. PubMed ID: 15671980
    [No Abstract]   [Full Text] [Related]  

  • 13. Implementation of the Comprehensive Methamphetamine Control Act of 1996; regulation of pseudoephedrine, phenylpropanolamine, and combination ephedrine drug products and reports of certain transactions to nonregulated persons. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2002 Mar; 67(60):14853-62. PubMed ID: 11922057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revised product labels for pediatric over-the-counter cough and cold medicines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(43):1180. PubMed ID: 18971921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the origin of ephedrine and methamphetamine by stable isotope ratio mass spectrometry: a Japanese experience.
    Makino Y; Urano Y; Nagano T
    Bull Narc; 2005; 57(1-2):63-78. PubMed ID: 21338016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schedules of Controlled Substances: Table of Excluded Nonnarcotic Products: Vicks® VapoInhaler®.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Feb; 81(25):6451-3. PubMed ID: 26859905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. For young children, many OTC products are out in the cold.
    Sinclair E; Fiechtner HB
    S D Med; 2009 Jun; 62(6):236-7. PubMed ID: 19650276
    [No Abstract]   [Full Text] [Related]  

  • 18. Schedules of Controlled Substances: Table of Excluded Nonnarcotic Products: Nasal Decongestant Inhaler/Vapor Inhaler. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Feb; 81(25):6453-4. PubMed ID: 26859907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of methamphetamine precursor chemical legislation, a suppression policy, on the demand for drug treatment.
    Cunningham JK; Liu LM
    Soc Sci Med; 2008 Apr; 66(7):1463-73. PubMed ID: 18222587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impacts of federal precursor chemical regulations on methamphetamine arrests.
    Cunningham JK; Liu LM
    Addiction; 2005 Apr; 100(4):479-88. PubMed ID: 15784062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.